The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Recentin     4-[(4-fluoro-2-methyl-1H- indol-5-yl)oxy]-6...

Synonyms: Cadiranib, Cediranib, QCR-93, SureCN63147, Kinome_3318, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Recentin

 

Associations of Recentin with other chemical compounds

References

  1. AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor. Takeda, M., Arao, T., Yokote, H., Komatsu, T., Yanagihara, K., Sasaki, H., Yamada, Y., Tamura, T., Fukuoka, K., Kimura, H., Saijo, N., Nishio, K. Clin. Cancer Res. (2007) [Pubmed]
  2. Phase I study of cediranib in combination with oxaliplatin and infusional 5-Fluorouracil in patients with advanced colorectal cancer. Chen, E., Jonker, D., Gauthier, I., MacLean, M., Wells, J., Powers, J., Seymour, L. Clin. Cancer Res. (2009) [Pubmed]
  3. The tyrosine kinase inhibitor, AZD2171, inhibits vascular endothelial growth factor receptor signaling and growth of anaplastic thyroid cancer in an orthotopic nude mouse model. Gomez-Rivera, F., Santillan-Gomez, A.A., Younes, M.N., Kim, S., Fooshee, D., Zhao, M., Jasser, S.A., Myers, J.N. Clin. Cancer Res. (2007) [Pubmed]
  4. Inhibition of vascular endothelial growth factor-a signaling induces hypertension: examining the effect of cediranib (recentin; AZD2171) treatment on blood pressure in rat and the use of concomitant antihypertensive therapy. Curwen, J.O., Musgrove, H.L., Kendrew, J., Richmond, G.H., Ogilvie, D.J., Wedge, S.R. Clin. Cancer Res. (2008) [Pubmed]
 
WikiGenes - Universities